BibTex Citation Data :
@article{JPKI2547, author = {M. Arie Wuryanto}, title = {Tingkat Kepatuhan Penderita Malaria Vivax Dalam Minum Obat Serta Faktor Yang Mempengaruhinya Studi Pada Penderita Malaria Vivax Di Kabupaten Banjarnegara Tahun 2005}, journal = {Jurnal Promosi Kesehatan Indonesia}, volume = {3}, number = {1}, year = {2012}, keywords = {}, abstract = { Background : Since 2003 until March 2004 malaria cases in Banjarnegara was still high.The proportion of plasmodium vivax more higher ( 60%) than falciparum (40%). It’s mean reflecting incompliance of malaria drug treatment. The study was intended to know level of compliance and identified same factors that related with compliance of malaria drug treatment. Method : This research was used Cross sectional design. Cases were patients of malaria vivax where detected since October 2004 until March 2005. Respondent more than 15 years age, and was used 14 days treatment method. This study was take 120 respondents of malaria vivax cases. Result : Malaria vivax cases who incompliance were 64%, it’s mean that level of compliance were 36%. Reason for stopping treatment was caused by feeling healthy of patients after 3 or 5 days of malaria drug treatment. The result of chi-square test showed a significant association between the level of patient knowledge and level compliance of malaria drug treatment (p-value = 0.002, ratio prevalent = 4,8 ( 95% CI: 1,7 - 13,7)). Level compliance of malaria drug treatment was depended on level of patient knowledge. Patient with poor knowledge had 4,8 times to become incompliance of malaria drug treatment. Keyword : Compliance, malaria drug treatment, malaria vivax }, issn = {2620-4053}, pages = {24--30} doi = {10.14710/jpki.3.1.24-30}, url = {https://ejournal.undip.ac.id/index.php/jpki/article/view/2547} }
Refworks Citation Data :
Article Metrics:
Last update:
Last update: 2024-12-17 11:45:23
Authors retain copyright and grant Jurnal Promosi Kesehatan Indonesia by http://ejournal.undip.ac.id/index.php/jpki the right of first publication. The work is simultaneously licensed under a Creative Commons Attribution-ShareAlike 4.0 International License which allows others to share, adapt, and build upon the work for any purpose, provided appropriate credit is given to the authors and the journal as the original source of publication and any derivative works are distributed under the same license.
Authors may enter into separate, additional contractual arrangements for non-exclusive distribution of the journal's published version of the work (e.g., depositing it in institutional repositories or publishing it as part of a book) with acknowledgment of its initial publication in this journal.
Additionally, authors are encouraged to post their work online (e.g. Sherpa/Romeo) prior to and during the submission process to foster academic exchange and increase visibility and citation of their work. The license ensures that users give appropriate attribution, indicate if changes were made, and do not apply legal terms or technological measures that restrict others from any activity permitted under the license.
View statistics